Although our knockdown and overexpression experiments clearly showed the causality between IGF2BP2 expression and NASH development, the reason for the rapid occurrence of NASH by IGF2BP2 overexpression remains unknown. Here, IGF2BP2 is linked to metabolic dysfunction-associated steatohepatitis.